Результаты исследований: Научные публикации в периодических изданиях › Обзорная статья › Рецензирование
Optimizatsiya gipolipidemicheskoi terapii u patsientov, perenesshikh ishemicheskii insul't. Rezolyutsiya Soveta ekspertov. / Vozniuk, I. A.; Shamalov, N. A.; Ezhov, M. V.; Tikhomirova, O. V.; Gurevich, V. S.; Kucherenko, S. S.; Konovalov, G. A.; Konstantinov, V. O.; Ershova, A. I.
в: Zhurnal Nevrologii i Psihiatrii imeni S.S. Korsakova, Том 120, № 6, 2020, стр. 152-161.Результаты исследований: Научные публикации в периодических изданиях › Обзорная статья › Рецензирование
}
TY - JOUR
T1 - Optimizatsiya gipolipidemicheskoi terapii u patsientov, perenesshikh ishemicheskii insul't. Rezolyutsiya Soveta ekspertov
AU - Vozniuk, I. A.
AU - Shamalov, N. A.
AU - Ezhov, M. V.
AU - Tikhomirova, O. V.
AU - Gurevich, V. S.
AU - Kucherenko, S. S.
AU - Konovalov, G. A.
AU - Konstantinov, V. O.
AU - Ershova, A. I.
N1 - Funding Information: Совет Экспертов проводился при поддержке компании «Амджен». The Expert Council was supported by Amgen. Publisher Copyright: © 2020, Media Sphera Publishing Group. All rights reserved.
PY - 2020
Y1 - 2020
N2 - Hyperlipidemia is the main risk factor for diseases caused by atherosclerosis including ischemic stroke. This publication provides practical recommendations and an algorithm for prescribing lipid-lowering therapy to post-ischemic stroke patients. The algorithm presents the steps for sequential administration of statins, ezetimibe, and PCSK9 inhibitors to achieve target levels of low-density lipoprotein cholesterol.
AB - Hyperlipidemia is the main risk factor for diseases caused by atherosclerosis including ischemic stroke. This publication provides practical recommendations and an algorithm for prescribing lipid-lowering therapy to post-ischemic stroke patients. The algorithm presents the steps for sequential administration of statins, ezetimibe, and PCSK9 inhibitors to achieve target levels of low-density lipoprotein cholesterol.
KW - Anticholesteremic Agents
KW - Brain Ischemia/drug therapy
KW - Humans
KW - Hydroxymethylglutaryl-CoA Reductase Inhibitors
KW - Proprotein Convertase 9
KW - Stroke/drug therapy
UR - http://www.scopus.com/inward/record.url?scp=85088222272&partnerID=8YFLogxK
U2 - 10.17116/jnevro2020120061152
DO - 10.17116/jnevro2020120061152
M3 - Обзорная статья
C2 - 32678563
AN - SCOPUS:85088222272
VL - 120
SP - 152
EP - 161
JO - ЖУРНАЛ НЕВРОЛОГИИ И ПСИХИАТРИИ ИМ. C.C. КОРСАКОВА
JF - ЖУРНАЛ НЕВРОЛОГИИ И ПСИХИАТРИИ ИМ. C.C. КОРСАКОВА
SN - 1997-7298
IS - 6
ER -
ID: 88168067